General Information

MaintermGlucopon 215 UP
CAS Reg.No.(or other ID)68515-73-1
Regnum

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID3033856
IUPAC Name(3R,4S,5S,6R)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol
InChIInChI=1S/C16H32O6/c1-2-3-4-5-6-7-8-9-10-21-16-15(20)14(19)13(18)12(11-17)22-16/h12-20H,2-11H2,1H3/t12-,13-,14+,15-,16?/m1/s1
InChI KeyJDRSMPFHFNXQRB-IWQYDBTJSA-N
Canonical SMILESCCCCCCCCCCOC1C(C(C(C(O1)CO)O)O)O
Molecular FormulaC16H32O6
Wikipediadecyl glucoside

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight320.426
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count11
Complexity275.0
CACTVS Substructure Key Fingerprint A A A D c f B 4 O A A A A A A A A A A A A A A A A A A A A A A A A A A k A A A A A A A A A A A A A A A A G g A A C A A A C B S w g A M C C A A A B g A A A A A A A A A A A A A A A A A A A A A A A A A R E A I A A A A i Q A A F A A A H A A H A 4 K w A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area99.4
Monoisotopic Mass320.22
Exact Mass320.22
XLogP3None
XLogP3-AA2.4
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count22
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB-0.5311
Human Intestinal AbsorptionHIA-0.5967
Caco-2 PermeabilityCaco2-0.7406
P-glycoprotein SubstrateSubstrate0.6838
P-glycoprotein InhibitorNon-inhibitor0.7730
Non-inhibitor0.8709
Renal Organic Cation TransporterNon-inhibitor0.8330
Distribution
Subcellular localizationMitochondria0.7706
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8441
CYP450 2D6 SubstrateNon-substrate0.8238
CYP450 3A4 SubstrateNon-substrate0.5586
CYP450 1A2 InhibitorNon-inhibitor0.8661
CYP450 2C9 InhibitorNon-inhibitor0.8839
CYP450 2D6 InhibitorNon-inhibitor0.9200
CYP450 2C19 InhibitorNon-inhibitor0.7443
CYP450 3A4 InhibitorNon-inhibitor0.8685
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.9235
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.8624
Non-inhibitor0.6009
AMES ToxicityNon AMES toxic0.8908
CarcinogensNon-carcinogens0.9490
Fish ToxicityLow FHMT0.5899
Tetrahymena Pyriformis ToxicityHigh TPT0.9725
Honey Bee ToxicityHigh HBT0.6542
BiodegradationReady biodegradable0.7562
Acute Oral ToxicityIII0.5272
Carcinogenicity (Three-class)Non-required0.7075

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-1.4197LogS
Caco-2 Permeability-0.3330LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity1.4828LD50, mol/kg
Fish Toxicity2.4039pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.5603pIGC50, ug/L

From admetSAR


Taxonomic Classification

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClassFatty Acyls
SubclassFatty acyl glycosides
Intermediate Tree NodesNot available
Direct ParentFatty acyl glycosides of mono- and disaccharides
Alternative Parents
Molecular FrameworkAliphatic heteromonocyclic compounds
SubstituentsFatty acyl glycoside of mono- or disaccharide - Alkyl glycoside - Hexose monosaccharide - Glycosyl compound - O-glycosyl compound - Monosaccharide - Oxane - Secondary alcohol - Acetal - Organoheterocyclic compound - Oxacycle - Polyol - Organooxygen compound - Primary alcohol - Hydrocarbon derivative - Organic oxygen compound - Alcohol - Aliphatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. These are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol.

From ClassyFire